Utilizing a larger cohort of 175 NPC and 61 non-cancerous nasopharyngeal epithelia cases, we demonstrated that loss of FOXA1 was significantly associated with larger tumor size, lymphatic metastasis, distant metastasis, advanced clinical stages, and the undifferentiated histological subtype. Here, FOXA1 is linked to neoplasm.